Posts With Tag Edesa Biotech

Explore Edesa Biotech, Inc.'s 8-K report, filed on February 12, 2025, detailing crucial updates for shareholders. Focused on corporate governance and compliance.

Discover the latest insights from Edesa Biotech's Amendment No. 1 to their Annual Report 10-K, detailing shareholder disclosures and filing updates for FY 2024.